Oral CGRP receptor antagonist approved for migraine prevention. Used off-label in some Long COVID patients suffering from chronic headaches or post-viral migraines.
Information
Subcategory
CGRP receptor antagonist (gepant)
Evidence type
case reports and extrapolation from migraine evidence
Share your experience
Your feedback helps thousands of people find what really works.